NCT05011019 2024-03-21
A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Terminated
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Nobelpharma
PTC Therapeutics
Novartis